American Board of Internal Medicine (ABIM) Certification Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the ABIM Certification Exam. Use flashcards and multiple choice questions, with hints and explanations for each. Get ready to succeed!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which BMI criteria allow for pharmacologic therapy in weight management?

BMI of 25 or higher
BMI of 30 or higher
BMI of 27 or higher with comorbidities
Both B and C

The correct answer is: Both B and C

Pharmacologic therapy for weight management is typically recommended based on specific Body Mass Index (BMI) criteria and the presence of obesity-related health conditions. The correct option includes both a BMI of 30 or higher, which indicates obesity, and a BMI of 27 or higher when there are associated comorbidities such as hypertension, type 2 diabetes, or dyslipidemia. A BMI of 30 or higher identifies individuals who fall into the category of obesity, which is a significant risk factor for various health issues. Pharmacologic interventions are often considered necessary in this group due to the increased likelihood of complications related to obesity. Additionally, when individuals present with a BMI of 27 or higher alongside comorbid conditions, pharmacologic treatment can also be warranted. This reflects a more nuanced understanding that even individuals with a slightly elevated BMI can benefit from medications if their health is at risk due to related conditions. Thus, both criteria are valid for initiating pharmacologic therapy, supporting the conclusion that options indicating either a BMI of 30 or higher or a BMI of 27 with comorbidities are appropriate for the management of weight through medication.